TuHURA Biosciences, Inc.
- HURA
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Cancer Immunotherapy
$1.76
Today −3.83%Quote Oct 16, 2026, 08:00 PM UTC
−15.79%over the last month
Max drawdown −19.3%From 1-month high −19.3%3 months −21.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$112.2M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.71
2.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HURAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
22